Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization

被引:6
|
作者
Lu, Jun Ling [1 ]
Molnar, Miklos Z. [1 ,2 ]
Sumida, Keiichi [1 ,3 ,4 ]
Diskin, Charles D. [5 ]
Streja, Elan [6 ]
Siddiqui, Omer A. [1 ]
Kalantar-Zadeh, Kamyar [6 ]
Kovesdy, Csaba P. [1 ,7 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[2] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[3] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan
[4] Univ Tsukuba, Fac Med, Dept Nephrol, Ibaraki, Japan
[5] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[6] Univ Calif Irvine, Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Div Nephrol & Hypertens, Orange, CA USA
[7] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN 38104 USA
关键词
chronic kidney disease; end-stage renal disease; hospitalization; mortality; pre-ESRD laboratory testing; CHRONIC KIDNEY-DISEASE; PREDIALYSIS NEPHROLOGY CARE; GLOMERULAR-FILTRATION-RATE; SERUM POTASSIUM; OUTCOMES; MANAGEMENT; SURVIVAL; DIALYSIS; ANEMIA; INITIATION;
D O I
10.1093/ndt/gfx192
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Previous studies have demonstrated that early pre-end-stage renal disease (ESRD) nephrology care could improve postdialysis prognosis. However, less is known about the specific types of interventions responsible for the improved outcomes. We hypothesized that more frequent predialysis laboratory testing is associated with better postdialysis outcomes in incident ESRD patients. Methods. In all, 23 089 patients with available outpatient laboratory tests performed during the 2-year predialysis (i.e. prelude) period were identified from a total of 52 172 American veterans with chronic kidney disease (CKD) transitioning to dialysis between October 2007 and September 2011. The associations between the frequency of combined laboratory tests, including serum creatinine, serum potassium and hemoglobin (test trio), with postdialysis mortality and hospitalization were examined in multivariable adjusted Cox and logistic regression models. Results. When entering the 2-year prelude period, the mean age (Standard Deviation) of the patients was 66.2 (SD 11.3) years and the mean estimated glomerular filtration rate was 46.8 (SD 23.9) mL/min/1.73 m(2). In all, 14% of patients had the test trio performed less than twice in 24 months and 8.9% had the trio measured more often than every other month. Over a 2.5-year median postdialysis follow-up period, 15 303 (66.3%) patients died (mortality rate 260/1000 patient-years). The adjusted hazard ratio of all-cause mortality and adjusted odds ratio of the composite of hospitalization or death associated with lab testing done >12/24 months compared with 2-<= 4/24 months were 0.68 [95% confidence interval (CI) 0.65-0.73] and 0.70 (95% CI 0.62-0.79), respectively. Conclusions. More frequent laboratory testing in patients with advanced CKD is associated with better clinical outcomes after dialysis. Further examination in clinical trials is needed before the implementation of more frequent laboratory testing in clinical practice.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [21] Medical options to fight mortality in end-stage renal disease: a review of the literature
    Kramann, Rafael
    Floege, Juergen
    Ketteler, Markus
    Marx, Nikolaus
    Brandenburg, Vincent M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (12) : 4298 - 4307
  • [22] Depression and Mortality in End-Stage Renal Disease
    Nisha Ver Halen
    Daniel Cukor
    Melissa Constantiner
    Paul L. Kimmel
    Current Psychiatry Reports, 2012, 14 : 36 - 44
  • [23] The epidemiology of atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Liu, Tong
    Letsas, Konstantinos P.
    Fragakis, Nikolaos
    Kyrlas, Konstantinos
    Goudevenos, John A.
    JOURNAL OF NEPHROLOGY, 2013, 26 (04) : 617 - 623
  • [24] End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes
    Nguyen, Kevin A.
    Vourganti, Srinivas
    Syed, Jamil S.
    Luciano, Randy
    Campbell, Steven C.
    Shuch, Brian
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (08) : 529.e1 - 529.e7
  • [25] Inflammation, Left Ventricular Hypertrophy, and Mortality in End-stage Renal Disease
    Cafka, Majlinda
    Rroji, Merita
    Seferi, Saimir
    Barbullushi, Myftar
    Burazeri, Genc
    Spahia, Nereida
    Idrizi, Alma
    Likaj, Erjola
    Seiti, Joana
    Lazaj, Jonida
    Goda, Artan
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (04) : 217 - 223
  • [26] Thyroid disease in end-stage renal disease
    Rhee, Connie M.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06) : 621 - 630
  • [27] Pregnancy in advanced chronic kidney disease and end-stage renal disease
    Alkhunaizi, Ahd
    Melamed, Nir
    Hladunewich, Michelle A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (03) : 252 - 259
  • [28] Frailty in end stage renal disease: Current perspectives
    Nagaraju, Shankar Prasad
    Shenoy, Srinivas Vinayak
    Gupta, Ankur
    NEFROLOGIA, 2022, 42 (05): : 531 - 539
  • [29] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [30] Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease
    Tsai, Yi-Chun
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Wang, Shu-Li
    Hsiao, Shih-Ming
    Lin, Ming-Yen
    Kung, Lan-Fang
    Hsiao, Pei-Ni
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1621 - 1626